Abstract
Objective
To assess the utility of continuous metabolic syndrome score (cMetS) for predicting metabolic syndrome (MS) and determine the cut-off values in overweight and obese children.
Methods
This study was conducted among 104 children (7–14 y) attending obesity clinics of a tertiary care hospital in Mumbai, India. The cMetS was computed by standardizing the residuals of waist circumference (WC), mean arterial blood pressure (MAP), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) by regressing them according to age and sex and aggregating them. The optimal cut-off of cMetS for predicting MS was determined by the receiver operation characteristic (ROC) curve analysis.
Results
The cMetS increased significantly with increase in the number of MS risk factors. It was significantly high in children with MS than those without it (boys: 1.070 + 1.834 vs. -1.478 + 2.262; girls: 2.092 + 1.963 vs. -2.253 + 2.140; combined children group: 1.572 + 1.950 vs. -1.907+ 2.374; p < 0.001). The score predicted MS with high accuracy in girls; (AUC of 0.95, 95% CI: 0.90–1.00), moderate accuracy in boys (AUC of 0.79, 95% CI: 0.65–0.92) and in the combined group (AUC of 0.87, 95% CI 0.80–0.94) respectively. The cut-off of cMetS yielding maximal sensitivity and specificity for predicting the MS was −1.009 in boys (sensitivity 93% and specificity 62%); −0.652 in girls (sensitivity 96.4% and specificity 77%) and − 0.6881 in the combined group (sensitivity 91.2% and specificity 70.2%).
Conclusions
cMetS predicted MS with moderate to high accuracy. It had high sensitivity and specificity in predicting MS in overweight and obese children.
Similar content being viewed by others
References
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–421.
Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–78.
Thivel D, Malina RM, Isacco L, Aucouturier J, Meyer M, Duche' P. Metabolic syndrome in obese children and adolescents: dichotomous or continuous? Metab Syndr Relat Disord. 2009;7:549–55.
Heshmat R, Heidari M, Ejtahed HS, et al. Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study. Diabetol Metab Syndr. 2017;9:89.
Guseman EH, Eisenmann JC, Laurson KR, Cook SR, Stratbucker W. Calculating a continuous metabolic syndrome score using nationally representative reference values. Acad Pediatr. 2018;18:589–92.
Minakshi B, Chithambaram NS. Early identification of risk factors and diagnosis of metabolic syndrome in overweight and obese children above 6 years of age. Int J Contemp Pediatrics. 2017;4:1439–44.
Kahn R, Ferrannini E, Buse J, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of diabetes. Diabetes Care. 2005;28:2289–304.
Villa JKD, e Silva AR, Santos TSS, Ribeiro AQ, Sant'Ana LFdaR. Metabolic syndrome risk assessment in children: use of a single score. Rev Paul Pediatr [Internet]. 2015;33:187–93. Available at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822015000200187&lng=en. https://doi.org/10.1016/j.rpped.2014.11.001. Accessed 15 April 2019.
Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol. 2008;7:17.
Kelly AS, Steinberger J, Jacobs DR, Hong CP, Moran A, Sinaiko AR. Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood. Int J Pediatr Obes. 2011;6:e283–9.
Khadilkar A, Ekbote V, Chiplonkar S, et al. Waist circumference percentiles in 2-18 year old indian children. J Pediatr. 2014;164:1358–62.
Khadilkar V, Yadav S, Agrawal KK, et al. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr. 2015;52:47–55.
Report of the Second Task Force on Blood Pressure Control in Children—1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;379:1–25.
Majid H, Masood Q, Khan AH. Homeostatic model assessment for insulin resistance (HOMA-IR): a better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome. J Coll Physicians Surg Pak. 2017;27:123–6.
de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–7.
Wittcopp C, Conroy R. Metabolic syndrome in children and adolescents. Pediatr Rev. 2016;37:193–202.
Pandit D, Chiplonkar S, Khadilkar A, Kinare A, Khadilkar V. Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk. Int J Obes [Internet]. 2011;35:1318–24.
Okosun IS, Boltri JM, Lyn R, Davis-Smith M. Continuous metabolic syndrome risk score, body mass index percentile, and leisure time physical activity in American children. J Clin Hypertens. 2010;12:636–44.
Andrabi SMS, Bhat MH, Andrabi SR, et al. Prevalence of metabolic syndrome in 8-18-year-old school-going children of Srinagar city of Kashmir India. Indian J Endocr Metab. 2013;17:95–100.
Tandon N, Garg MK, Singh Y, Marwaha RK. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR). J Pediatr Endocrinol Metab. 2013;26:1123–30.
Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. The relation of childhood BMI to adult adiposity: the Bogalusa heart study. Pediatrics. 2005;115:22–7.
Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GDC. Predictors of metabolically healthy obesity in children. Diabetes Care. 2014;37:1462–8.
Magnussen CG, Cheriyan S, Sabin MA, et al. Continuous and dichotomous metabolic syndrome definitions in youth predict adult type 2 diabetes and carotid artery intima media thickness: the cardiovascular risk in young Finns study. J Pediatr. 2016;171:97–103.e3.
Stavnsbo M, Resaland GK, Anderssen SA, et al. Reference values for cardiometabolic risk scores in children and adolescents: suggesting a common standard. Atherosclerosis. 2018;278:299–306.
Acknowledgements
The authors thank all children and their parents who agreed for the participation in this study. They acknowledge help of Dr. Susan Cherian, Head Pathology, BARC Hospital and Dr. A. R. Kulkarni, MO-In-charge, Medical Section, BARC Hospital.
Author information
Authors and Affiliations
Contributions
SPS: Data collection, statistical analysis, manuscript preparation and editing the manuscript. ASA: Data collection and editing the manuscript. ASA is the guarantor for this paper.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sawant, S.P., Amin, A.S. Use of Continuous Metabolic Syndrome Score in Overweight and Obese Children. Indian J Pediatr 86, 909–914 (2019). https://doi.org/10.1007/s12098-019-02994-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-019-02994-5